This report examines the biological mechanisms of ultraviolet (UV) induced skin damage and the pharmacological role of sunscreens in mitigating these effects.

本報告探討紫外線 (UV) 引起皮膚損傷的生物機制，以及防曬產品在緩解這些影響方面的藥理作用。

The pathogenesis of photodamage is predicated on the absorption of photons by cutaneous molecules. Ultraviolet radiation is bifurcated into UVA (320-400 nm) and UVB (280-320 nm) spectra. UVA radiation penetrates the dermis more profoundly, precipitating the degradation of collagen and subsequent loss of elasticity, whereas UVB radiation is the primary catalyst for erythema. Both spectra can induce DNA mutations and the generation of reactive oxygen species (ROS), which may overwhelm endogenous antioxidant networks and lead to the development of non-melanoma and melanoma carcinomas. These effects are universal across all Fitzpatrick skin types, notwithstanding the varying degrees of melanin-mediated protection.

光損傷的致病機制基於皮膚分子對光子的吸收。紫外線輻射分為 UVA (320-400 nm) 與 UVB (280-320 nm) 兩種光譜。UVA 輻射能更深層地滲透至真皮層，導致膠原蛋白降解並隨後失去彈性，而 UVB 輻射則是引起紅斑的主要催化劑。兩種光譜均可誘導 DNA 突變並產生活性氧類 (ROS)，這可能會使內源性抗氧化網絡負荷過重，進而導致非黑色素瘤與黑色素瘤的發生。無論是哪種 Fitzpatrick 皮膚類型，儘管黑色素介導的保護程度有所不同，但這些影響是普遍存在的。

To counteract these processes, photoprotective agents employ UV filters. Chemical filters absorb radiation and convert it into thermal energy, while physical blockers, such as zinc oxide and titanium dioxide, reflect photons from the skin surface. The United States Food and Drug Administration (FDA) regulates these agents as drugs, mandating specific labeling for Sun Protection Factor (SPF)—a measure of UVB protection duration—and 'Broad Spectrum' designations, which require verification of UVA efficacy. The stability of these filters is a critical variable; for instance, the photolability of avobenzone necessitates stabilization via agents like octocrylene or ethylhexyl methoxycrylene to maintain efficacy.

為了對抗這些過程，光防護劑採用了 UV 濾光劑。化學濾光劑吸收輻射並將其轉化為熱能，而物理遮蔽劑（如氧化鋅和二氧化鈦）則將光子從皮膚表面反射。美國食品藥物管理局 (FDA) 將這些劑劑定義為藥品進行監管，要求標明防曬係數 (SPF) —— 衡量 UVB 保護時長的指標 —— 以及「寬頻」標記，後者需要驗證其 UVA 功效。這些濾光劑的穩定性是一個關鍵變數；例如，Avobenzone 的光不穩定性需要透過 Octocrylene 或 Ethylhexyl Methoxycrylene 等藥劑進行穩定，以維持其功效。

Clinical efficacy is frequently compromised by suboptimal application protocols. Research indicates that a significant proportion of users apply insufficient quantities of product and fail to adhere to reapplication schedules, particularly in humid environments or following aquatic activity. Furthermore, medical professionals emphasize that UV radiation persists through cloud cover and glass, rendering daily application necessary regardless of indoor status or skin pigmentation. The integration of antioxidants, such as Vitamins C and E, is increasingly utilized to provide a secondary defense against oxidative stress that escapes primary UV filters.

臨床功效經常因塗抹方案不佳而受到影響。研究指出，很大比例的使用者塗抹量不足，且未能遵守補塗時間表，尤其是在潮濕環境或水上活動之後。此外，醫療專業人員強調，紫外線可穿透雲層與玻璃，因此無論是否處於室內或皮膚色素沉著如何，每日塗抹皆屬必要。加入維生素 C 與 E 等抗氧化劑的趨勢日益增加，旨在為逃避初步 UV 濾光劑的氧化壓力提供第二道防線。

Consistent application of broad-spectrum photoprotective agents remains the primary method for reducing the incidence of skin cancer and premature dermal aging.

持續使用寬頻光防護劑，仍是降低皮膚癌發生率與延緩皮膚早衰的主要方法。